Inhibitors of JNK
    1.
    发明授权
    Inhibitors of JNK 失效
    JNK抑制剂

    公开(公告)号:US08536172B2

    公开(公告)日:2013-09-17

    申请号:US12852540

    申请日:2010-08-09

    IPC分类号: A61K31/495

    CPC分类号: C07D403/04 C07D401/14

    摘要: The invention relates to JNK inhibitors and corresponding methods, formulations, and compositions for inhibiting JNK and treating JNK-mediated disorders. The application discloses JNK inhibitors, as described below in Formula I: wherein p, q, Y′, r, R1, R2, X, X1, X2, X3, and X4 are as defined herein. The compounds and compositions disclosed herein are useful to modulate the activity of JNK and treat diseases associated with JNK activity. Disclosed are methods and formulations for inhibiting JNK and treating JNK-mediated disorders, and the like, with the compounds, and processes for making said compounds, and corresponding compositions, disclosed herein.

    摘要翻译: 本发明涉及JNK抑制剂和用于抑制JNK和治疗JNK介导的病症的相应方法,制剂和组合物。 本申请公开了如下式I所述的JNK抑制剂:其中p,q,Y',r,R 1,R 2,X,X 1,X 2,X 3和X 4如本文所定义。 本文公开的化合物和组合物可用于调节JNK的活性并治疗与JNK活性相关的疾病。 公开了用于抑制JNK和治疗JNK介导的病症等的方法和制剂,以及本文公开的化合物,以及制备所述化合物的方法和相应的组合物。

    Inhibitors of JNK
    2.
    发明申请
    Inhibitors of JNK 失效
    JNK抑制剂

    公开(公告)号:US20110034470A1

    公开(公告)日:2011-02-10

    申请号:US12852540

    申请日:2010-08-09

    CPC分类号: C07D403/04 C07D401/14

    摘要: The invention relates to JNK inhibitors and corresponding methods, formulations, and compositions for inhibiting JNK and treating JNK-mediated disorders. The application discloses JNK inhibitors, as described below in Formula I: wherein p, q, Y′, r, R1, R2, X, X1, X2, X3, and X4 are as defined herein. The compounds and compositions disclosed herein are useful to modulate the activity of JNK and treat diseases associated with JNK activity. Disclosed are methods and formulations for inhibiting JNK and treating JNK-mediated disorders, and the like, with the compounds, and processes for making said compounds, and corresponding compositions, disclosed herein.

    摘要翻译: 本发明涉及JNK抑制剂和用于抑制JNK和治疗JNK介导的病症的相应方法,制剂和组合物。 本申请公开了如下式I所述的JNK抑制剂:其中p,q,Y',r,R 1,R 2,X,X 1,X 2,X 3和X 4如本文所定义。 本文公开的化合物和组合物可用于调节JNK的活性并治疗与JNK活性相关的疾病。 公开了用于抑制JNK和治疗JNK介导的病症等的方法和制剂,以及本文公开的化合物,以及制备所述化合物的方法和相应的组合物。